arrow
J

Jae Ho Jeong

university of ulsan
H指数:25
被引数:2,428

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)

MIRINAE试验(一项比较辅助阿替利珠单抗联合卡培他滨与单用卡培他滨的随机II期试验;KCSG-BR18-21)中,新辅助化疗后残留浸润性三阴性乳腺癌的基因组学和转录组学分析

2025-09-240
PREAI
Clinical benefit of adjuvant capecitabine according to residual cancer burden in patients with triple-negative breast cancer with residual disease following neoadjuvant chemotherapy

新辅助化疗后仍有残留病灶的三阴性乳腺癌患者中,根据残留肿瘤负荷评价辅助卡培他滨的临床获益

2025-09-190
PRE
Predictive and prognostic value of 18F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors

18F-FES PET/CT对接受内分泌治疗联合 cyclin-dependent kinase 4/6 抑制剂治疗的复发性或转移性乳腺癌患者的预测和预后价值

2025-01-140
PRE
Longitudinal dynamics of circulating tumor DNA for treatment monitoring in patients with breast cancer recurrence

循环肿瘤DNA纵向动力学在乳腺癌复发患者治疗监测中的应用

2024-08-311
OAAI